Experimental & Molecular Medicine

Fig. 6: The prognostic risk predictive ability of TMB, RMS and CRMS subgroups for the HNSC CCRT cohort. | Experimental & Molecular Medicine

Fig. 6: The prognostic risk predictive ability of TMB, RMS and CRMS subgroups for the HNSC CCRT cohort.

From: The role of the genomic mutation signature and tumor mutation burden on relapse risk prediction in head and neck squamous cell carcinoma after concurrent chemoradiotherapy

Fig. 6: The prognostic risk predictive ability of TMB, RMS and CRMS subgroups for the HNSC CCRT cohort.

Search

Advanced search

Quick links